Investing Ideas
/
Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

4 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

31 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
XSPRAY Xspray Pharma	SEK 30.85	-3.9%	-25.1%	SEK 1.1b	SEK 55.50	PB1.8x	E104.9%	n/a
INIT Initiator Pharma	SEK 7.30	5.0%	-12.0%	SEK 409.8m	SEK 22.50	PB17.3x	E31.7%	n/a
ACE Ascelia Pharma	SEK 3.37	10.9%	-59.2%	SEK 323.9m	SEK 7.68	PB4.1x	E66.9%	n/a
CLBIO Corline Biomedical	SEK 10.45	-6.7%	-20.8%	SEK 255.9m	SEK 20.50	PS14.8x	E105.9%	n/a
CAMX Camurus	SEK 659.50	12.4%	47.7%	SEK 38.7b	SEK 757.67	PE90.3x	E50.4%	n/a
KLAR Klaria Pharma Holding AB (publ.)	SEK 1.70	5.9%	312.6%	SEK 246.1m	SEK 1.20	PB19.1x	E93.9%	n/a
DVYSR Devyser Diagnostics	SEK 130.50	-6.1%	45.6%	SEK 2.2b	SEK 164.98	PS10x	E96.9%	n/a
XBRANE Xbrane Biopharma	SEK 0.16	-7.6%	-93.0%	SEK 243.6m	SEK 0.45	PS1.2x	E128.5%	n/a
BONEX Bonesupport Holding	SEK 343.40	-0.4%	78.3%	SEK 22.6b	SEK 422.33	PE249.5x	E73.1%	n/a
BIOA B BioArctic	SEK 235.20	8.4%	6.6%	SEK 20.8b	SEK 331.60	PS80.8x	E41.4%	0%
EGTX Egetis Therapeutics	SEK 4.99	-15.1%	-19.6%	SEK 1.8b	SEK 11.40	PS26.4x	E97.3%	n/a
NEWBRY Newbury Pharmaceuticals	SEK 3.32	-2.9%	-22.6%	SEK 80.5m	SEK 8.00	PS2.5x	E146.2%	n/a
KAN Kancera	SEK 1.03	1.6%	-75.0%	SEK 124.8m	SEK 3.10	PB1.7x	E48.3%	n/a
LPGO Lipigon Pharmaceuticals	SEK 0.14	-14.7%	-66.3%	SEK 21.0m	SEK 0.90	PS2.3x	E139.5%	n/a
SPAGO Spago Nanomedical	SEK 0.21	0%	-29.1%	SEK 73.1m	SEK 0.74	PS10.6x	E18.6%	n/a
SENZA SenzaGen	SEK 6.05	-13.6%	-10.5%	SEK 178.5m	SEK 14.50	PS3.1x	E133.9%	n/a
ACTI New Active Biotech	SEK 0.091	-12.2%	-85.4%	SEK 111.7m	SEK 0.34	PB3.4x	E101.2%	n/a
BINV BioInvent International	SEK 23.30	-3.3%	49.0%	SEK 1.5b	SEK 90.00	PS39.7x	E108.6%	n/a
IMMU New Mendus	SEK 8.10	4.5%	-19.0%	SEK 407.9m	SEK 30.00	PS80.8x	E13.4%	n/a
MOB New Moberg Pharma	SEK 9.28	15.7%	-43.1%	SEK 433.3m	SEK 11.10	PS44.2x	E107.5%	n/a
ALIF B AddLife	SEK 167.50	-3.7%	65.8%	SEK 20.4b	SEK 184.00	PE81x	E30.2%	0.4%
ORX Orexo	SEK 16.98	6.0%	18.9%	SEK 585.9m	SEK 20.50	PS1x	E81.0%	n/a
BIOG B BioGaia	SEK 131.00	1.7%	4.8%	SEK 13.3b	SEK 150.00	PE37.7x	E13.9%	5.3%
SECARE Swedencare	SEK 45.06	-5.1%	-25.8%	SEK 7.2b	SEK 58.67	PE72.4x	E40.0%	0.6%

Page 1 of 2